logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
03/11/2026
DuPont expects fourth-quarter net sales of approximately $1.83 billion, versus the market expectation of $1.82 billion.
Latest
4 m ago
Pfizer (PFE.N): Third-quarter revenue declined on an operational basis, mainly due to lower revenues from COVID-19 products, the Prevnar series, and several products across other categories.
4 m ago
Jushuitan (06687.HK) repurchased 557,000 shares for HKD 5.8575 million on November 3.
5 m ago
Iraq's Oil Minister: An agreement has been reached with US Chevron regarding the West Qurna-2 oil field.
5 m ago
Huihan Co., Ltd. (301600.SZ) plans to repurchase company shares for RMB 50 million to RMB 100 million.
6 m ago
Pfizer (PFE.N) expects full-year revenue of $62 billion to $64 billion, compared with its previous forecast of $60.5 billion to $62.5 billion.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.